ANALYST RECOMMENDATIONS : AstraZeneca, Diageo, Hays, NatWest, PageGroup...
RBC devoted a study to the European temporary employment sector, PageGroup. Berenberg raised its price target on NatWest and Victrex. The density of recommendations is lower than usual due to the approach of quarterly results, which start this week before accelerating considerably the following week.
- AstraZeneca: Jefferies advises its customers to buy the stock. The target price is being increased from GBp 8850 to GBp 9950.
- AO World: Jefferies upgrades from hold to buy, targeting GBp 400.
- Diageo: Barclays maintains its Buy rating. The target price is now set at GBp 3940 versus GBp 3850.
- Easyjet: JP Morgan retains his Neutral opinion on the stock. The target price continues to be set at GBp 845.
- Hays: RBC upgrades from sector perform to outperform, targeting GBP 195.
- International Consolidated Airlines Group: JP Morgan research considers the stock attractive and recommends it with a Buy rating.
- NatWest: Berenberg remains Buy with target price raised to GBP 240 from GBP 230.
- PageGroup: RBC upgrades from Market Perform to Outperform with a target of GBP 700.
- Reinsurance Group: J.P. Morgan upgrades to overweight from neutral. PT set to $138, a 22% increase from last price.
- Ryanair: JP Morgan maintained its recommendation on the stock with a Neutral rating. The target price is increased from EUR 15.80 to EUR 16.40.
- Victrex: Berenberg remains a Hold with a price target raised from GBp 2,500 to 2,600.
By 
